LOWERING CYCLOSPORINE DOSE IS NOT ASSOCIATED WITH AN INCREASED RISK OF GASTRO-INTESTINAL ADVERSE EVENTS NOR THE NEED FOR DOSAGE DECREASE OF MYCOPHENOLATE MOFETIL.
Kreis, H, Miloradovich, T, Mourad, G, Cointault, O, Berthoux, F, Delahousse, M, Cassuto, E, Chalopin, J -M., Glotz, D, Lebranchu, Y, Legendre, C, Merville, P, Touraine, J -L., Vialtel, P, Wolf, P, MouVolume:
78
Language:
english
Journal:
Transplantation Journal
DOI:
10.1097/00007890-200407271-01239
Date:
July, 2004
File:
PDF, 409 KB
english, 2004
File converter
More search results
More benefits 
